FFR Guidewire Improves Percutaneous Coronary Interventions
By HospiMedica International staff writers Posted on 27 Oct 2016 |
Image: The PressureWire X Guidewire for FFR measurement (Photo courtesy of St. Jude Medical).
An improved guidewire provides physicians with fractional flow reserve (FFR) measurements in order to gauge narrowed coronary arteries.
The St. Jude Medical (SJM; St. Paul, MN, USA) PressureWire X Guidewire Measurement System has been redesigned to adapt to unique, complex anatomies in order to support more accurate lesion assessment during percutaneous coronary intervention (PCI). The tip of the guidewire can be shaped and re-shaped throughout the PCI procedure, enabling access to multiple lesions. The guidewire also provides enhanced durability and improved handling, in either a cabled or wireless configuration.
Concomitant to the launching the latest PressureWire X Guidewire iteration, SJM has also launched the PRESSUREwire multicenter clinical trial in order to determine the routine use of FFR measurement and clinical outcomes of FFR-guided PCI in patients with acute coronary syndrome (ACS), a major cause of global morbidity and mortality. The PRESSUREwire REGISTRY will build upon clinical trials designed to assess the positive outcomes associated with FFR technology.
“St. Jude Medical strives to provide physicians with fractional flow reserve pressure guidewire technology that is backed by ample clinical data, and that matches the handling performance of conventional PCI guidewires,” said Mark Carlson, MD, chief medical officer and vice president of global medical affairs at St. Jude Medical. “The new PressureWire X Guidewire shows our dedication to providing physicians with cost-effective, easy-to-use technologies that aid them in making the best treatment decisions for their patients.”
“Clinical research has confirmed that fractional flow reserve is one of the most important tools available when assessing coronary lesions and making informed treatment decisions during percutaneous coronary intervention,” said Annapoorna Kini, MD, director of the cardiac catheterization lab at Mount Sinai Medical Center (New York, NY, USA). “The improved design and shape retention of the new PressureWire X Guidewire tip allows us to perform FFR measurements in more tortuous anatomies.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
St. Jude Medical
The St. Jude Medical (SJM; St. Paul, MN, USA) PressureWire X Guidewire Measurement System has been redesigned to adapt to unique, complex anatomies in order to support more accurate lesion assessment during percutaneous coronary intervention (PCI). The tip of the guidewire can be shaped and re-shaped throughout the PCI procedure, enabling access to multiple lesions. The guidewire also provides enhanced durability and improved handling, in either a cabled or wireless configuration.
Concomitant to the launching the latest PressureWire X Guidewire iteration, SJM has also launched the PRESSUREwire multicenter clinical trial in order to determine the routine use of FFR measurement and clinical outcomes of FFR-guided PCI in patients with acute coronary syndrome (ACS), a major cause of global morbidity and mortality. The PRESSUREwire REGISTRY will build upon clinical trials designed to assess the positive outcomes associated with FFR technology.
“St. Jude Medical strives to provide physicians with fractional flow reserve pressure guidewire technology that is backed by ample clinical data, and that matches the handling performance of conventional PCI guidewires,” said Mark Carlson, MD, chief medical officer and vice president of global medical affairs at St. Jude Medical. “The new PressureWire X Guidewire shows our dedication to providing physicians with cost-effective, easy-to-use technologies that aid them in making the best treatment decisions for their patients.”
“Clinical research has confirmed that fractional flow reserve is one of the most important tools available when assessing coronary lesions and making informed treatment decisions during percutaneous coronary intervention,” said Annapoorna Kini, MD, director of the cardiac catheterization lab at Mount Sinai Medical Center (New York, NY, USA). “The improved design and shape retention of the new PressureWire X Guidewire tip allows us to perform FFR measurements in more tortuous anatomies.”
FFR is a physiological index used to determine the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of the flow of blood to a patient’s heart muscle, and helps guide interventional cardiologists in determining which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs.
Related Links:
St. Jude Medical
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Latest Surgical Techniques News
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices